Fundraising Fox

Deep Blue Medical Advances

Durham, US · Founded 2015 · Delaware corporation

Founders & leadership

WP
William PerryExecutive
HL
Howard LevinsonNamed on SEC filing
KG
Ken GallNamed on SEC filing
RI
Robert IsaacsNamed on SEC filing

Board

MB
Michael BatesBoard director
NM
Neil MeyerBoard director
BD
Brent DuncanBoard director
RB
Robert BonczekBoard director

Reported raises · per SEC filings

Form D private placements

$18.1M disclosed across 6 rounds · 2017–2025

$5.3MraisedSep 2025 · 105 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Howard LevinsonExecutive Officer, Director
  • William PerryExecutive Officer, Director
  • Michael BatesDirector
  • Neil MeyerDirector
  • Brent DuncanDirector
Offering amount
$5.7M
Amount sold
$5.3M
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$7MraisedJun 2022 · 113 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael BatesDirector
  • Ken GallDirector
  • William PerryExecutive Officer, Director, Promoter
  • Howard LevinsonExecutive Officer, Director, Promoter
  • Brent DuncanDirector
Offering amount
$7.5M
Amount sold
$7M
First sale
Jun 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.4MraisedFeb 2021 · 106 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael BatesDirector
  • Howard LevinsonExecutive Officer, Director, Promoter
  • William PerryExecutive Officer, Director, Promoter
  • Ken GallDirector
Offering amount
$3.5M
Amount sold
$3.4M
First sale
Jun 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.6MraisedJan 2021 · 73 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ken GallDirector
  • Michael BatesDirector
  • Brent DuncanDirector
  • Howard LevinsonExecutive Officer, Director, Promoter
  • William PerryExecutive Officer, Director, Promoter
Offering amount
$1.6M
Amount sold
$1.6M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$295KraisedAug 2018 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William PerryExecutive Officer, Director, Promoter
  • Robert IsaacsDirector
  • Howard LevinsonExecutive Officer, Director, Promoter
  • Robert BonczekDirector
  • Ken GallDirector
Offering amount
$295K
Amount sold
$295K
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$517KraisedJan 2018 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Howard LevinsonExecutive Officer, Director, Promoter
  • William PerryExecutive Officer, Director, Promoter
  • Robert BonczekDirector
  • Ken GallDirector
  • Robert IsaacsDirector
Offering amount
$800K
Amount sold
$517K
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

How much funding has Deep Blue Medical Advances raised?
Deep Blue Medical Advances has disclosed $18.1M raised across 6 rounds.
Where is Deep Blue Medical Advances headquartered?
Deep Blue Medical Advances is headquartered in Durham, US.